$GYHT Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in HALOZYME THERAPEUTICS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in HALOZYME THERAPEUTICS, INC.. Get notifications about new insider transactions in HALOZYME THERAPEUTICS, INC. for free.
Page: < prev 1 ... 3 4 5 6 7 8 9 10 11 ... 15 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 11 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 8.63 | 710 | 6,127 | 43,900 | 44.6 K to 43.9 K (-1.59 %) |
| Oct 11 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 8.62 | 390 | 3,362 | 44,610 | 45 K to 44.6 K (-0.87 %) |
| Oct 02 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 9.00 | 519 | 4,671 | 45,000 | 45.5 K to 45 K (-1.14 %) |
| Oct 02 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 8.99 | 381 | 3,425 | 45,519 | 45.9 K to 45.5 K (-0.83 %) |
| Oct 02 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 8.98 | 1,400 | 12,572 | 45,900 | 47.3 K to 45.9 K (-2.96 %) |
| Oct 02 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 8.97 | 200 | 1,794 | 47,300 | 47.5 K to 47.3 K (-0.42 %) |
| Oct 02 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 8.96 | 100 | 896 | 47,500 | 47.6 K to 47.5 K (-0.21 %) |
| Oct 02 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 8.95 | 600 | 5,370 | 47,600 | 48.2 K to 47.6 K (-1.24 %) |
| Oct 02 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 8.94 | 800 | 7,152 | 48,200 | 49 K to 48.2 K (-1.63 %) |
| Oct 02 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 8.93 | 300 | 2,679 | 49,000 | 49.3 K to 49 K (-0.61 %) |
| Oct 02 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 8.92 | 368 | 3,283 | 49,300 | 49.7 K to 49.3 K (-0.74 %) |
| Oct 02 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 8.91 | 1,132 | 10,086 | 49,668 | 50.8 K to 49.7 K (-2.23 %) |
| Oct 02 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 8.90 | 900 | 8,010 | 50,800 | 51.7 K to 50.8 K (-1.74 %) |
| Oct 02 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 8.89 | 2,295 | 20,403 | 51,700 | 54 K to 51.7 K (-4.25 %) |
| Oct 02 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 8.88 | 900 | 7,992 | 53,995 | 54.9 K to 54 K (-1.64 %) |
| Oct 02 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 8.87 | 561 | 4,976 | 54,895 | 55.5 K to 54.9 K (-1.01 %) |
| Oct 02 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 8.86 | 2,075 | 18,385 | 55,456 | 57.5 K to 55.5 K (-3.61 %) |
| Oct 02 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 8.85 | 405 | 3,584 | 57,531 | 57.9 K to 57.5 K (-0.70 %) |
| Oct 02 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 8.84 | 500 | 4,420 | 57,936 | 58.4 K to 57.9 K (-0.86 %) |
| Oct 02 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 8.83 | 300 | 2,649 | 58,436 | 58.7 K to 58.4 K (-0.51 %) |
| Oct 02 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 8.82 | 164 | 1,446 | 58,736 | 58.9 K to 58.7 K (-0.28 %) |
| Oct 02 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 8.81 | 300 | 2,643 | 58,900 | 59.2 K to 58.9 K (-0.51 %) |
| Oct 02 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 8.80 | 300 | 2,640 | 59,200 | 59.5 K to 59.2 K (-0.50 %) |
| Oct 02 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 8.79 | 500 | 4,395 | 59,500 | 60 K to 59.5 K (-0.83 %) |
| Oct 02 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Option Exercise | M | 0.39 | 25,000 | 9,750 | 2,254,003 | |
| Oct 02 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.59 | 200 | 1,718 | 673,310 | 673.5 K to 673.3 K (-0.03 %) |
| Oct 02 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.63 | 300 | 2,589 | 673,510 | 673.8 K to 673.5 K (-0.04 %) |
| Oct 02 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.65 | 100 | 865 | 673,810 | 673.9 K to 673.8 K (-0.01 %) |
| Oct 02 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.66 | 400 | 3,464 | 673,910 | 674.3 K to 673.9 K (-0.06 %) |
| Oct 02 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.67 | 400 | 3,468 | 674,310 | 674.7 K to 674.3 K (-0.06 %) |
| Oct 02 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.68 | 300 | 2,604 | 674,710 | 675 K to 674.7 K (-0.04 %) |
| Oct 02 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.69 | 500 | 4,345 | 675,010 | 675.5 K to 675 K (-0.07 %) |
| Oct 02 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.70 | 700 | 6,090 | 675,510 | 676.2 K to 675.5 K (-0.10 %) |
| Oct 02 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.71 | 3,500 | 30,485 | 676,210 | 679.7 K to 676.2 K (-0.51 %) |
| Oct 02 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.72 | 950 | 8,284 | 679,710 | 680.7 K to 679.7 K (-0.14 %) |
| Oct 02 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.73 | 276 | 2,409 | 680,660 | 680.9 K to 680.7 K (-0.04 %) |
| Oct 02 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.74 | 224 | 1,958 | 680,936 | 681.2 K to 680.9 K (-0.03 %) |
| Oct 02 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.75 | 1,500 | 13,125 | 681,160 | 682.7 K to 681.2 K (-0.22 %) |
| Oct 02 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.76 | 1,350 | 11,826 | 682,660 | 684 K to 682.7 K (-0.20 %) |
| Oct 02 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.77 | 600 | 5,262 | 684,010 | 684.6 K to 684 K (-0.09 %) |
| Oct 02 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.78 | 600 | 5,268 | 684,610 | 685.2 K to 684.6 K (-0.09 %) |
| Oct 02 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.79 | 900 | 7,911 | 685,210 | 686.1 K to 685.2 K (-0.13 %) |
| Oct 02 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.80 | 3,010 | 26,488 | 686,110 | 689.1 K to 686.1 K (-0.44 %) |
| Oct 02 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.81 | 1,610 | 14,184 | 689,120 | 690.7 K to 689.1 K (-0.23 %) |
| Oct 02 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.82 | 1,100 | 9,702 | 690,730 | 691.8 K to 690.7 K (-0.16 %) |
| Oct 02 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.83 | 1,880 | 16,600 | 691,830 | 693.7 K to 691.8 K (-0.27 %) |
| Oct 02 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.84 | 400 | 3,536 | 693,710 | 694.1 K to 693.7 K (-0.06 %) |
| Oct 02 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.85 | 600 | 5,310 | 694,110 | 694.7 K to 694.1 K (-0.09 %) |
| Oct 02 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.88 | 700 | 6,216 | 694,710 | 695.4 K to 694.7 K (-0.10 %) |
| Oct 02 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.89 | 1,299 | 11,548 | 695,410 | 696.7 K to 695.4 K (-0.19 %) |
| Oct 02 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.90 | 600 | 5,340 | 696,709 | 697.3 K to 696.7 K (-0.09 %) |
| Oct 02 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.91 | 201 | 1,791 | 697,309 | 697.5 K to 697.3 K (-0.03 %) |
| Oct 02 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.92 | 700 | 6,244 | 697,510 | 698.2 K to 697.5 K (-0.10 %) |
| Oct 02 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.93 | 100 | 893 | 698,210 | 698.3 K to 698.2 K (-0.01 %) |
| Oct 02 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Buy | M | 0.39 | 25,000 | 9,750 | 698,310 | 673.3 K to 698.3 K (+3.71 %) |
| Sep 28 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Option Exercise | M | 0.43 | 52,602 | 22,619 | 846,455 | |
| Sep 28 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Payment of Exercise | F | 8.69 | 2,602 | 22,611 | 3,069,606 | 3.1 M to 3.1 M (-0.08 %) |
| Sep 28 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Buy | M | 0.43 | 52,602 | 22,619 | 3,072,208 | 3 M to 3.1 M (+1.74 %) |
| Sep 28 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Option Exercise | M | 0.43 | 15,757 | 6,776 | 899,057 | |
| Sep 28 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 9.23 | 400 | 3,692 | 3,019,606 | 3 M to 3 M (-0.01 %) |
| Sep 28 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 9.20 | 255 | 2,346 | 3,020,006 | 3 M to 3 M (-0.01 %) |
| Sep 28 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 9.19 | 100 | 919 | 3,020,261 | 3 M to 3 M (0.00 %) |
| Sep 28 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 9.16 | 100 | 916 | 3,020,361 | 3 M to 3 M (0.00 %) |
| Sep 28 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 9.15 | 445 | 4,072 | 3,020,461 | 3 M to 3 M (-0.01 %) |
| Sep 28 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 9.12 | 300 | 2,736 | 3,020,906 | 3 M to 3 M (-0.01 %) |
| Sep 28 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 9.09 | 200 | 1,818 | 3,021,206 | 3 M to 3 M (-0.01 %) |
| Sep 28 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 9.08 | 400 | 3,632 | 3,021,406 | 3 M to 3 M (-0.01 %) |
| Sep 28 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 9.06 | 200 | 1,812 | 3,021,806 | 3 M to 3 M (-0.01 %) |
| Sep 28 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 9.05 | 200 | 1,810 | 3,022,006 | 3 M to 3 M (-0.01 %) |
| Sep 28 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.98 | 200 | 1,796 | 3,022,206 | 3 M to 3 M (-0.01 %) |
| Sep 28 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.95 | 400 | 3,580 | 3,022,406 | 3 M to 3 M (-0.01 %) |
| Sep 28 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.92 | 229 | 2,043 | 3,022,806 | 3 M to 3 M (-0.01 %) |
| Sep 28 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.91 | 300 | 2,673 | 3,023,035 | 3 M to 3 M (-0.01 %) |
| Sep 28 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.90 | 800 | 7,120 | 3,023,335 | 3 M to 3 M (-0.03 %) |
| Sep 28 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.89 | 800 | 7,112 | 3,024,135 | 3 M to 3 M (-0.03 %) |
| Sep 28 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.88 | 1,171 | 10,398 | 3,024,935 | 3 M to 3 M (-0.04 %) |
| Sep 28 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.87 | 1,200 | 10,644 | 3,026,106 | 3 M to 3 M (-0.04 %) |
| Sep 28 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.86 | 2,100 | 18,606 | 3,027,306 | 3 M to 3 M (-0.07 %) |
| Sep 28 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.85 | 700 | 6,195 | 3,029,406 | 3 M to 3 M (-0.02 %) |
| Sep 28 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.84 | 100 | 884 | 3,030,106 | 3 M to 3 M (0.00 %) |
| Sep 28 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.83 | 1,400 | 12,362 | 3,030,206 | 3 M to 3 M (-0.05 %) |
| Sep 28 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.82 | 1,200 | 10,584 | 3,031,606 | 3 M to 3 M (-0.04 %) |
| Sep 28 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.81 | 500 | 4,405 | 3,032,806 | 3 M to 3 M (-0.02 %) |
| Sep 28 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.80 | 100 | 880 | 3,033,306 | 3 M to 3 M (0.00 %) |
| Sep 28 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.79 | 300 | 2,637 | 3,033,406 | 3 M to 3 M (-0.01 %) |
| Sep 28 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.77 | 700 | 6,139 | 3,033,706 | 3 M to 3 M (-0.02 %) |
| Sep 28 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.76 | 200 | 1,752 | 3,034,406 | 3 M to 3 M (-0.01 %) |
| Sep 28 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Payment of Exercise | F | 8.95 | 757 | 6,775 | 3,034,606 | 3 M to 3 M (-0.02 %) |
| Sep 28 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Buy | M | 0.43 | 15,757 | 6,776 | 3,035,363 | 3 M to 3 M (+0.52 %) |
| Sep 28 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Option Exercise | M | 0.43 | 15,746 | 6,771 | 914,814 | |
| Sep 28 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 9.23 | 300 | 2,769 | 3,019,606 | 3 M to 3 M (-0.01 %) |
| Sep 28 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 9.22 | 200 | 1,844 | 3,019,906 | 3 M to 3 M (-0.01 %) |
| Sep 28 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 9.21 | 600 | 5,526 | 3,020,106 | 3 M to 3 M (-0.02 %) |
| Sep 28 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 9.17 | 500 | 4,585 | 3,020,706 | 3 M to 3 M (-0.02 %) |
| Sep 28 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 9.16 | 300 | 2,748 | 3,021,206 | 3 M to 3 M (-0.01 %) |
| Sep 28 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 9.15 | 300 | 2,745 | 3,021,506 | 3 M to 3 M (-0.01 %) |
| Sep 28 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 9.14 | 300 | 2,742 | 3,021,806 | 3 M to 3 M (-0.01 %) |
| Sep 28 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 9.12 | 1,600 | 14,592 | 3,022,106 | 3 M to 3 M (-0.05 %) |
| Sep 28 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 9.11 | 400 | 3,644 | 3,023,706 | 3 M to 3 M (-0.01 %) |
| Sep 28 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 9.10 | 400 | 3,640 | 3,024,106 | 3 M to 3 M (-0.01 %) |
| Sep 28 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 9.08 | 700 | 6,356 | 3,024,506 | 3 M to 3 M (-0.02 %) |
| Sep 28 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 9.07 | 700 | 6,349 | 3,025,206 | 3 M to 3 M (-0.02 %) |
| Sep 28 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 9.06 | 1,090 | 9,875 | 3,025,906 | 3 M to 3 M (-0.04 %) |
| Sep 28 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 9.04 | 410 | 3,706 | 3,026,996 | 3 M to 3 M (-0.01 %) |
| Sep 28 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 9.02 | 900 | 8,118 | 3,027,406 | 3 M to 3 M (-0.03 %) |
| Sep 28 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 9.01 | 2,200 | 19,822 | 3,028,306 | 3 M to 3 M (-0.07 %) |
| Sep 28 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 9.00 | 1,400 | 12,600 | 3,030,506 | 3 M to 3 M (-0.05 %) |
| Sep 28 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.99 | 400 | 3,596 | 3,031,906 | 3 M to 3 M (-0.01 %) |
| Sep 28 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.98 | 500 | 4,490 | 3,032,306 | 3 M to 3 M (-0.02 %) |
| Sep 28 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.97 | 400 | 3,588 | 3,032,806 | 3 M to 3 M (-0.01 %) |
| Sep 28 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.96 | 400 | 3,584 | 3,033,206 | 3 M to 3 M (-0.01 %) |
| Sep 28 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.95 | 700 | 6,265 | 3,033,606 | 3 M to 3 M (-0.02 %) |
| Sep 28 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.93 | 300 | 2,679 | 3,034,306 | 3 M to 3 M (-0.01 %) |
| Sep 28 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Payment of Exercise | F | 9.07 | 746 | 6,766 | 3,034,606 | 3 M to 3 M (-0.02 %) |
| Sep 28 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Buy | M | 0.43 | 15,746 | 6,771 | 3,035,352 | 3 M to 3 M (+0.52 %) |
| Sep 26 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 9.10 | 200 | 1,820 | 60,000 | 60.2 K to 60 K (-0.33 %) |
| Sep 26 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 9.09 | 100 | 909 | 60,200 | 60.3 K to 60.2 K (-0.17 %) |
| Sep 26 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 9.08 | 200 | 1,816 | 60,300 | 60.5 K to 60.3 K (-0.33 %) |
| Sep 26 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 9.06 | 200 | 1,812 | 60,500 | 60.7 K to 60.5 K (-0.33 %) |
| Sep 26 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 9.05 | 300 | 2,715 | 60,700 | 61 K to 60.7 K (-0.49 %) |
| Sep 26 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 9.02 | 900 | 8,118 | 61,000 | 61.9 K to 61 K (-1.45 %) |
| Sep 26 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 9.01 | 1,100 | 9,911 | 61,900 | 63 K to 61.9 K (-1.75 %) |
| Sep 26 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 9.00 | 1,441 | 12,969 | 63,000 | 64.4 K to 63 K (-2.24 %) |
| Sep 26 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 8.99 | 204 | 1,834 | 64,441 | 64.6 K to 64.4 K (-0.32 %) |
| Sep 26 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 8.98 | 500 | 4,490 | 64,645 | 65.1 K to 64.6 K (-0.77 %) |
| Sep 26 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 8.97 | 1,559 | 13,984 | 65,145 | 66.7 K to 65.1 K (-2.34 %) |
| Sep 26 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 8.96 | 396 | 3,548 | 66,704 | 67.1 K to 66.7 K (-0.59 %) |
| Sep 26 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 8.95 | 700 | 6,265 | 67,100 | 67.8 K to 67.1 K (-1.03 %) |
| Sep 26 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 8.94 | 1,000 | 8,940 | 67,800 | 68.8 K to 67.8 K (-1.45 %) |
| Sep 26 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 8.93 | 522 | 4,661 | 68,800 | 69.3 K to 68.8 K (-0.75 %) |
| Sep 26 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 8.92 | 700 | 6,244 | 69,322 | 70 K to 69.3 K (-1.00 %) |
| Sep 26 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 8.91 | 300 | 2,673 | 70,022 | 70.3 K to 70 K (-0.43 %) |
| Sep 26 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 8.90 | 200 | 1,780 | 70,322 | 70.5 K to 70.3 K (-0.28 %) |
| Sep 26 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 8.89 | 200 | 1,778 | 70,522 | 70.7 K to 70.5 K (-0.28 %) |
| Sep 26 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 8.88 | 200 | 1,776 | 70,722 | 70.9 K to 70.7 K (-0.28 %) |
| Sep 26 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 8.87 | 878 | 7,788 | 70,922 | 71.8 K to 70.9 K (-1.22 %) |
| Sep 26 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 8.86 | 200 | 1,772 | 71,800 | 72 K to 71.8 K (-0.28 %) |
| Sep 26 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 8.85 | 400 | 3,540 | 72,000 | 72.4 K to 72 K (-0.55 %) |
| Sep 26 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 8.84 | 500 | 4,420 | 72,400 | 72.9 K to 72.4 K (-0.69 %) |
| Sep 26 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 8.83 | 1,400 | 12,362 | 72,900 | 74.3 K to 72.9 K (-1.88 %) |
| Sep 26 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 8.82 | 600 | 5,292 | 74,300 | 74.9 K to 74.3 K (-0.80 %) |
| Sep 26 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 8.81 | 100 | 881 | 74,900 | 75 K to 74.9 K (-0.13 %) |
| Sep 20 2007 | GYHT | HALOZYME THERAPEUT ... | KIRK RANDAL J | Director | Buy | P | 9.00 | 23,085 | 207,765 | 3,970,000 | 3.9 M to 4 M (+0.58 %) |
| Sep 20 2007 | GYHT | HALOZYME THERAPEUT ... | KIRK RANDAL J | Director | Buy | P | 8.87 | 15,489 | 137,387 | 3,946,915 | 3.9 M to 3.9 M (+0.39 %) |
| Sep 19 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 9.05 | 700 | 6,335 | 75,000 | 75.7 K to 75 K (-0.92 %) |
| Sep 19 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 9.04 | 71 | 642 | 75,700 | 75.8 K to 75.7 K (-0.09 %) |
| Sep 19 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 9.02 | 100 | 902 | 75,771 | 75.9 K to 75.8 K (-0.13 %) |
| Sep 19 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 9.01 | 200 | 1,802 | 75,871 | 76.1 K to 75.9 K (-0.26 %) |
| Sep 19 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 9.00 | 3,100 | 27,900 | 76,071 | 79.2 K to 76.1 K (-3.92 %) |
| Sep 19 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 8.99 | 1,351 | 12,145 | 79,171 | 80.5 K to 79.2 K (-1.68 %) |